Anti-TIF1γ antibody-positive dermatomyositis associated with nivolumab administration in a patient with advanced oesophageal squamous cell carcinoma: A case report and literature review

被引：0
|
作者：
Sakurai, Takuya [1 ]
Takahashi, Junichiro [2 ,3 ]
Komatsu, Teppei [2 ]
Mitsumura, Hidetaka [2 ]
Iguchi, Yasuyuki [2 ]
机构：
[1] Jikei Univ, Sch Med, Dept Cardiol, Tokyo, Japan
[2] Jikei Univ, Sch Med, Dept Neurol, Tokyo, Japan
[3] Jikei Univ, Sch Med, Dept Neurol, 3-25-8 Nishi Shinbashi,Minato Ku, Tokyo 1058461, Japan
来源：
MODERN RHEUMATOLOGY CASE REPORTS | 2023年 / 7卷 / 02期
关键词：
TIF1 gamma antibody; dermatomyositis; immune-related adverse events; cancer; paraneoplastic syndrome; CANCER; AUTOANTIBODY;
D O I：
10.1093/mrcr/rxad007
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
We report a case of anti-transcriptional intermediary factor 1 gamma antibody-positive dermatomyositis following nivolumab treatment. The patient was successfully treated with pulse steroid therapy and high-dose intravenous immunoglobulin, followed by oral glucocorticoid treatment. Immune checkpoint inhibitors, such as nivolumab, may induce not only myositis as an immune-related adverse event but also dermatomyositides as a paraneoplastic syndrome by distracting immune tolerance. Differentiating between pathologies is warranted if patients develop myositis after immune checkpoint inhibitor administration.
引用
收藏
页码：416 / 421
页数：6
相关论文
共 50 条
  • [1] Anti-TIF1γ antibody-positive dermatomyositis associated with durvalumab administration in a patient with lung and oesophageal cancers
    Imai, Ryosuke
    Ikemura, Sumie
    Jinta, Torahiko
    RESPIROLOGY CASE REPORTS, 2021, 9 (04):
  • [2] Coexisting TIF1γ-positive Primary Pulmonary Lymphoepithelioma-like Carcinoma and Anti-TIF1γ Antibody-positive Dermatomyositis
    Nakanishi, Yu
    Yamaguchi, Kakuhiro
    Yoshida, Yusuke
    Sakamoto, Shinjiro
    Horimasu, Yasushi
    Masuda, Takeshi
    Nakashima, Taku
    Miyamoto, Shintarou
    Iwamoto, Hiroshi
    Hirata, Shintaro
    Fujitaka, Kazunori
    Hamada, Hironobu
    Sugiyama, Eiji
    Hattori, Noboru
    INTERNAL MEDICINE, 2020, 59 (20) : 2553 - 2558
  • [3] Transcriptional intermediary factor 1 (TIF1) and anti-TIF1γ antibody-positive dermatomyositis
    Kotobuki, Yorihisa
    Tonomura, Kyoko
    Fujimoto, Manabu
    IMMUNOLOGICAL MEDICINE, 2021, 44 (01) : 23 - 29
  • [4] Anti-transcription intermediary factor 1 gamma (TIF1γ) antibody-positive dermatomyositis associated with ascending colon cancer: a case report and review of the literature
    Ono, Ryohei
    Kumagae, Tomohiro
    Igasaki, Mari
    Murata, Takaaki
    Yoshizawa, Masaki
    Kitagawa, Izumi
    JOURNAL OF MEDICAL CASE REPORTS, 2021, 15 (01)
  • [5] Anti-transcription intermediary factor 1 gamma (TIF1γ) antibody-positive dermatomyositis associated with ascending colon cancer: a case report and review of the literature
    Ryohei Ono
    Tomohiro Kumagae
    Mari Igasaki
    Takaaki Murata
    Masaki Yoshizawa
    Izumi Kitagawa
    Journal of Medical Case Reports, 15
  • [6] Dermatomyositis with positive anti-TIF1 gamma antibodies in an adult female: A case report
    Adhikari, Krishna
    Pant, Prashant
    Bhandari, Sanjeev
    Paudel, Sandip
    Poudyal, Buddhi
    Sharma, Lucky
    Sigdel, Keshav Raj
    Subedi, Rojina
    CLINICAL CASE REPORTS, 2023, 11 (11):
  • [7] Clinical Characteristics of Anti-TIF-1γ Antibody-Positive Dermatomyositis Associated with Malignancy
    Harada, Yumi
    Tominaga, Masaki
    Iitoh, Eriko
    Kaieda, Shinjiro
    Koga, Takuma
    Fujimoto, Kiminori
    Chikasue, Tomonori
    Obara, Hitoshi
    Kakuma, Tatsuyuki
    Ida, Hiroaki
    Kawayama, Tomotaka
    Hoshino, Tomoaki
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (07)
  • [8] Clinical features of anti-TIF1-α antibody-positive dermatomyositis patients are closely associated with coexistent dermatomyositis-specific autoantibodies and anti-TIF1-γ or anti-Mi-2 autoantibodies
    Muro, Yoshinao
    Ishikawa, Asuka
    Sugiura, Kazumitsu
    Akiyama, Masashi
    RHEUMATOLOGY, 2012, 51 (08) : 1508 - 1513
  • [9] Anti-TIF1γ antibody predicted malignancy of thymic tumor with dermatomyositis as an "autoimmune tumor marker" A case report
    Karino, Kohei
    Fujieda, Yuichiro
    Kawamura, Takuya
    Abe, Nobuya
    Shimoyama, Shuhei
    Kono, Michihito
    Kato, Masaru
    Yasuda, Shinsuke
    Atsumi, Tatsuya
    MEDICINE, 2018, 97 (49)
  • [10] Anti-TIF1gamma Antibody-Positive Dermatomyositis Associated with Myelodysplastic Syndrome: Response to Treatment
    Lerman, Irina
    Richardson, Christopher T.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2019, 11 (09)
12345